FTY720: A novel approach to the treatment of hepatic ischemia-reperfusion injury

被引：15

作者：

ANselmo, DM

Amersi, FF

Shen, XD

Gao, F

Katori, M

Ke, B

Lassman, C

Coito, AJ

Brinkmann, V

Busuttil, RW

Kupiec-Weglinski, JW

Farmer, DG

机构：

[1] Univ Calif Los Angeles, Sch Med, Dumont UCLA Transplant Ctr, Los Angeles, CA 90095 USA

[2] Novartis Pharma AG, Transplantat Res, Basel, Switzerland

来源：

TRANSPLANTATION PROCEEDINGS | 2002年 / 34卷 / 05期

关键词：

D O I：

10.1016/S0041-1345(02)02933-0

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：1467 / 1468

页数：2

相关论文

共 5 条

[1] FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation
Brinkmann, V
Pinschewer, D
Chiba, K
Feng, LL
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (02) : 49 - 52
[2] Inhibition of Kupffer cells reduced CXC chemokine production and liver injury
Mosher, B
Dean, R
Harkema, J
Remick, D
Palma, J
Crockett, E
[J]. JOURNAL OF SURGICAL RESEARCH, 2001, 99 (02) : 201 - 210
[3] Influence of ischemia-reperfusion injury on rejection after liver transplantation
Pirenne, J
Gunson, B
Khaleef, H
Hubscher, S
Afford, S
McMaster, P
Adams, D
[J]. TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 366 - 367
[4] SUZUKI S, 1993, TRANSPLANTATION, V55, P1265
[5] CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver
Zwacka, RM
Zhang, YL
Halldorson, J
Schlossberg, H
Dudus, L
Engelhardt, JF
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) : 279 - 289